RNA Outsourcing Solutions
-
Expanding Cell & Gene Therapy Global Supply Chain Offerings
7/26/2023
As cell and gene therapies continue to transform modern medicine, Cryoport Systems evolves its products and solutions to meet the needs of the industry and the patients it serves.
-
mRNA Vaccines And Therapeutics
1/28/2025
With our scale and experience in both chemistry and biologics, Curia is uniquely positioned to provide mRNA drug development solutions.
-
Biologics Manufacturing
5/15/2024
Recipharm Advanced Bio GMP manufacturing units focus on process robustness and consistency to ensure product quality, purity and efficacy. Our multi-product manufacturing facilities feature state-of-the-art equipment for animal cell-derived viral and microbial products for your clinical trials in phase 1-2 and in accordance with cGMP guidelines.
-
Non-Viral Gene Delivery (NVGD) Using Polymeric-Nano Particles
Examine a NVGD platform that tackles the primary obstacle hindering gene editing therapies: efficient delivery. Utilizing engineered nanoparticles, the platform overcomes limitations associated with payload size.
-
Toxicology Support: Regulatory Strategy And Submission Support
12/2/2025
Eliminate delays and ensure seamless regulatory alignment with an experienced toxicology services team.
-
Cell Therapy Product Characterization Services
Our cell therapy product characterization services combine rapid PCR, ELISA and custom methods tailored to these product types from a single contract partner with fully compliant cGMP facilities and options for research grade testing available.
-
NanoImprove The Performance Of Your Biologic Formulation
11/20/2025
Unlock superior performance for peptides and proteins using nanotechnology. Achieve high drug loads for subcutaneous delivery and stable, aerodynamic dry powders for deep-lung inhalation.
-
Bridging The Gaps: Enhancing First And Last Mile Resilience
7/28/2025
Designed as a dedicated, short-range logistics service for the life sciences, Cryoshuttle reinforces chain of custody, ensures near real-time visibility, and preserves product integrity from start to finish.
-
Advancing Innovative Plasmid DNA Manufacturing Solutions For CGT
3/13/2025
Having produced over 185,000 DNA lots, including 5,000+ cGMP batches, we are a trusted partner in plasmid DNA production from discovery to commercialization.
-
Accelerate Development With Large-Scale mRNA And LNP Production
10/16/2024
Achieve scalable purity with Vernal Biosciences' mRNA and lipid nanoparticle (LNP) large-scale production, tailored to meet the demands of your preclinical studies, including dose range finding and toxicology assessments.